Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Cyclin-Dependent Kinases

Items 21-30 of 69

Page
per page
  1. K03861
    B6042 K03861
    Summary: CDK2 inhibitor
      ≥50.2 mg/mL
  2. AZD-5597
    B5926 AZD-5597
    Summary: Potent CDK inhibitor
      ≥1.82 mg/mL
  3. [Ala92]-p16 (84-103)
    B5220 [Ala92]-p16 (84-103)
    Summary: inhibitor of cyclin-dependent kinase-4 (cdk4)/cyclin D1
      Soluble to 2 mg/mL
  4. Purvalanol A
    B4990 Purvalanol A
    Summary: potent, and cell-permeable CDK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.45 mg/mL
  5. LDC000067
    B4754 LDC000067
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK9 inhibitor, novel and highly specific
      insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL
  6. THZ1 Hydrochloride
    B4736 THZ1 Hydrochloride
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor
      ≥30.13 mg/mL
  7. ML167
    B3707 ML167
    Target: Clk
    Summary: Clk4 inhibitor,highly selective
      insoluble in EtOH; insoluble in H2O; ≥16.75 mg/mL
  8. AMG 925
    B3277 AMG 925
    Target: Cyclin-Dependent Kinases|FLT3
    Summary: FLT3/CDK4 inhibitor,potent and selective
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  9. Ribociclib succinate
    B1084 Ribociclib succinate
    Summary: CDK4/6 inhibitor
      ≥25.85 mg/mL
  10. LEE011 hydrochloride
    B1083 LEE011 hydrochloride
    Summary: CDK inhibitor
      ≥12.7 mg/mL

Items 21-30 of 69

Page
per page